Follow the AMPLIFON share price and the full management transaction log of the company, a publicly traded company based in Italy. Shares are quoted on IT IT, under the oversight of Consob. Operating in the Health Care sector, AMPLIFON has recorded 52 insider filings. Market capitalisation: €2.4bn. The latest transaction was filed on 12 September 2025 (Sale). Among the most active insiders: GABRIELE GALLI. All data is accessible without an account.
52
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€9m
26 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate AMPLIFON Hold (neutral), based on 16 analysts. Average price target: €12.58.
16Σ signal
Buys ·€9m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 9,908 of 25,899 companies
57.9
score / 100
Value
67
Quality
49
FCF yld11%
Earn yld3.3%
EV/EBITDA9.0x
ROE6.2%
Gross mgn53%
Net mgn3.8%
Debt/EBITDA3.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4,307 shares@ €32.790.0060% mcap100.0% of flowShareXMILCONSOB:146270
25 of 52 declarations
About AMPLIFON
AMPLIFON is an Italian company specializing in hearing solutions, providing hearing aids and related services. It is listed on the Italian stock market, XMIL.